Tuesday, Sep 26, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | India | Plea In Sc Seeks Disclosure Of Clinical Trials Data For Covid 19 Vaccines

Plea in SC seeks disclosure of clinical trials data for COVID-19 vaccines

The plea filed through advocate Prashant Bhushan sought direction to the government to make public the segregated data of the clinical trials for the vaccines.

By ANI
Published Date - 04:11 PM, Fri - 14 May 21
Plea in SC seeks disclosure of clinical trials data for COVID-19 vaccines
whatsapp facebook twitter telegram

New Delhi: A plea has been filed in the Supreme Court seeking transparency in Covid-19 vaccine clinical trial and post-vaccination data, including the recording and reporting of adverse events.

The petition filed by Dr Jacob Puliyel, a former member of the National Technical Advisory Group on Immunisation, also prayed that the court may declare vaccination mandates as unconstitutional.

The plea filed through advocate Prashant Bhushan sought direction to the government to make public the segregated data of the clinical trials for the vaccines that are being administered to the population in India under the Emergency Use Authorisation granted by the Drugs Controller General of India (DCGI).

It asked the apex court to direct the government to disclose the post-vaccination data regarding adverse effects, on people who got infected with Covid, those who needed hospitalisation and those who died after such infection post-vaccination.

The petitioner also asked to direct the respondents to widely publicise the data collection of such adverse event through the advertisement of toll-free telephone numbers where such complaints can be registered.

“In India, the manner in which the vaccines have been licensed vitiates and even precludes the possibility that the vaccines can be evaluated objectively in the future. Under these circumstances the petitioner is forced to appeal to this court for public disclosure of trial data and post-vaccination data, as required by international medical norms,” it added.

It said authorities to carefully monitor vaccine recipients and publicly record all adverse events.

“In other countries, this type of observation has helped identify the occurrence of blood clots and strokes in vaccine recipients, plea further said, adding that many countries stopped administering the vaccine till they evaluated this occurrence and countries like Denmark have completely banned the use of the Astra Zeneca vaccine (branded as Covishield in India),” the plea stated.

India, with its huge population and numbers vaccinated, should have reported these adverse events first, petition further submitted. But due to poor follow-up, poor Adverse Events Following Immunization (AEFI) evaluation and suppression of data, these events have not been put in the public domain – endangering many more to suffer the same fate, it added.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • clinical trials
  • clinical trials data
  • Covid-19
  • Covid-19 vaccine clinical trial

Related News

  • Memorial for journalists killed during COVID-19 to be inaugurated on October 2

    Memorial for journalists killed during COVID-19 to be inaugurated on October 2

  • India records 40 fresh Covid-19 cases on Monday

    India records 40 fresh Covid-19 cases on Monday

  • India reports 70 new Covid-19 cases

    India reports 70 new Covid-19 cases

  • Opinion: Why slowing China worries West

    Opinion: Why slowing China worries West

  • Delhi CM approves Rs 1 crore ex gratia each to kin of 17 Covid warriors

    Delhi CM approves Rs 1 crore ex gratia each to kin of 17 Covid warriors

  • COVID-19: India reports 55 fresh cases on Friday

    COVID-19: India reports 55 fresh cases on Friday

Latest News

  • 7 Republican candidates to clash in 2nd presidential debate tomorrow

    7 mins ago
  • Rupee falls 8 paise to 83.21 against US dollar in early trade

    17 mins ago
  • South Korea’s Yoon calls for a strong military amid deepening North Korean-Russian ties

    22 mins ago
  • 26/11 case: Mumbai court to take up fresh charge sheet against terror accused Rana

    27 mins ago
  • Asian Games: Bhavani Devi bows loses to superior Chinese rival in quarter-final

    33 mins ago
  • Audio and video calls arriving on X only for premium users

    37 mins ago
  • Stock market opens with volatility: Sensex and Nifty experience decrease in values

    42 mins ago
  • 6.6-magnitude quake hits Philippines

    47 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam